FDA awards grant for phase 1 clinical trial of experimental AML/MDS treatment

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)-;two related blood diseases that disproportionally strike older adults-;are notoriously difficult to treat and associated with high relapse rates.

Lawmakers want to add more Chinese biotechs to defense list

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! It’s Meghana. Today,

April 2, 2024

Boehringer Ingelheim unveils mid-stage win for glucagon/GLP-1 candidate for MASH, kindling PhIII plans

Boehringer Ingelheim said on Monday that its “double G” metabolic dysfunction-associated steatohepatitis (MASH) drug delivered positive topline results in a Phase II trial. The company

February 27, 2024

Antioxidants stimulate the formation of new blood vessels in lung cancer tumors

Vitamin C and other antioxidants stimulate the formation of new blood vessels in lung cancer tumors, a new study from Karolinska Institutet published in The

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.